TNF-ALPHA BLOCKING AGENT FOR PREVENTING, SUPPRESSING AND/OR DELAYING THE ONSET OF TYPE 1… Application WO-2022171685-A1 World Intellectual Property Organisation (WIPO) 18 Aug 2022
Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo Grant US-11246915-B2 United States of America 15 Feb 2022
Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo Grant US-10799565-B2 United States of America 13 Oct 2020
Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo Grant US-10786555-B2 United States of America 29 Sep 2020